Lilly Tirzepatide Drug - Search News

Eli Lilly, India and drug Mounjaro

· 4d · on MSN

Eli Lilly allows Cipla to sell weight loss drug under new brand in India

Eli Lilly signed an agreement with Cipla, allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate brand in the country, the companies said on Thursday. Under the agreement,

Continue reading

How Eli Lilly’s weight-loss drug Mounjaro gained early lead against Novo Nordisk’s Wegovy in India

Zacks Investment Research on MSN · 2d

Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings

5don MSN

3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

Pressure rises on Novo as Innovent drug tops Ozempic

Lilly's GIP/GLP-1 agonist Mounjaro (tirzepatide) also outperformed Ozempic, and the formulation of the drug for obesity, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results